A Study to Evaluate Absorption, Distribution and Elimination of Mirabegron After Oral Administration to Non-elderly Healthy Chinese Subjects

Inclusion Criteria: * Body weight: (male) over 50.0kg and less than 80.0kg (female) over 40.0kg and less than 70.0kg * Body Mass Index: over 17.6 and less than 26.4 kg/m * Chinese subjects * Healthy judged by investigator or sub-investigator Exclusion Criteria: * Received any investigational drugs within 120 days before the screening assessment * Donated 400 mL of whole blood within 90 days, 200 mL of whole blood within 30 days, or blood components within 14 days before the screening assessment * Received medication within 7 days before hospital admission * A deviation from the assessment criteria of physical examinations or laboratory tests at screening or upon admission * History of drug allergies * With renal, hepatic, gastrointestinal, heart, cerebrovascular or respiratory diseases * Received mirabegron beforehand * Glaucoma patient